Upload
truonganh
View
216
Download
0
Embed Size (px)
Citation preview
Publications (International):
• Ramezani A, Aghasadeghi MR, Ahmadi F, Razeghi E, Eslamifar A, Banifazl
M, Sofian M, Bahramali G, Hekmat S and Aghakhani A. Reduction of
Isolated Anti-HBc and Occult HBV Infection in Dialysis Patients. Nephro-
Urology Monthly (in press)
• Ramezani A, Kalantar E, Aghakhani A, Banifazl M, Foroughi M, Hosseini S,
Eslamifar A, Esmaeilzadeh A, Sadrpour P and Mohraz M. Lack of Association
between Interleukin-10 Gene Promoter Polymorphisms with HIV
Susceptibility and Progression to AIDS. Iranian Journal of Pathology 10 (2),
141 -148 (2015)
• Eslamifar A, Ramezani A, Azadmanesh A, Bidari-Zerehpoosh F, Banifazl M
and Aghakhani A. Assessment of the Association between Human
Papillomavirus Infection and Breast Carcinoma. Iranian Journal of Pathology
10(1):41-46(2015)
• Aghakhani A, Hamkar R, Ramezani A, Bidari-Zerehpoosh F, Sabeti S,
Ghavami N, Banifazl M, Rashidi N, Eslamifar A. Lack of Human
Papillomavirus DNA in Colon Adenocarcinama and Adenoma. Journal of
Cancer Research and Therapeutics 10(3):531-534(2014)
• Eslamifar A, Ramezani A, Banifazl M, Sofian M , Mahdaviani F, Yaghmaie F,
Aghakhani A. Immunity to diphtheria and tetanus among blood donors in
Arak, central province of Iran. Iranian Journal of Microbiology 6(3):190-193
(2014)
• Sofian M, Velayati AA, Aghakhani A, McFarland W, Farazi AA, Banifazl M,
Eslamifar A, Ramezani A. Comparison of two durations of triple drug therapy
in patients with uncomplicated brucellosis: a randomized controlled trial.
Scandinavian Journal of Infectious Diseases 46(8):573-577 (2014)
• Ramezani A, Amirmoezi R, Volk JE, Aghakhani A, Zarinfar N, McFarland
W, Banifazl M, Mostafavi E, Eslamifar A and Sofian M. HCV, HBV, and
HIV seroprevalence, co-infections, and related behaviors among male
injection drug users in Arak, Iran. AIDS Care 26(9): 1122–1126 (2014)
• Ramezani A, Janbakhsh A, Gol-Mohammadi M, Banifazl M, Aghakhani A,
Eslamifar A, Pournasiri Z, ….. Serological Response to One Intradermal or
Intramuscular HBV Vaccine Booster Dose in HIV Infected Nonresponders to
Standard Vaccination. Perspective in Clinical Research 5 (3):134-8(2014)
• Sofian M, …., Banifazl M, Aghakhani A, Eslamifar A, ……and Ramezani A.
Hematological Reference Values for Healthy Males in the Central Part of Iran.
Iranian Journal of Pathology 9(1):50-55 (2014)
• Sofian M, Aghakhani A, Banifazl M, Eslamifar A, Zolfaghari F, Sarmadian H,
Ramezani A. Differentiation of Brucella-Induced Epididymo-orchitis from
Nonspecific Epididymo-orchitis in an Endemic Area for Brucellosis. J Med
Microbiol Infec Dis.1 (1): 8-13 (2013)
• Ramezani A, Eslamifar A, Banifazl M and Aghakhani A. Importance of
Isolated Anti-HBc in Detection of Occult Hepatitis B Virus Infection in
Hemodialysis Patients. Therapeutic Apheresis and Dialysis 17(6):644 (2013)
• Sofian M, Safaeipour L, Aghakhani A, Sharif MR, Banifazl M, ….. Eslamifar
A, … Ramezani A. Screening of Family Members of Patients with Acute
Brucellosis in an Endemic Area. Iranian Journal of Microbiology 5(3):215-
219(2013)
• Ramezani A, …….., Eslamifar A , Mohraz M, Banifazl M, Bidari-Zerehpoosh
F, Yaghmaei F, McFarland W, …….., Mostafavi E and Aghakhani A.
Hepatitis E Virus Infection in Patients Infected with HIV in an Endemic Area
in Iran. International Journal of STD & AIDS 24(10) 769–774 (2013)
• Ehteram H, Ramezani A, Eslamifar A, Sofian M, Banifazl M, Ghassemi SH,
Aghakhani A, Mashayekhi P. Seroprevalence of Hepatitis E Virus infection
among Volunteer Blood Donors in Central Province of Iran in 2012. Iranian
Journal of Microbiology 5(2):172-176(2013)
• Aghasadeghi MR, Mohraz M, Bahramali G, Aghakhani A, Banifazl M, ….,
Eslamifar A, Sadat M, Ramezani A . Frequency and Genotype of Hepatitis D
Virus Infection in Patients Infected with HIV and Hemodialysis Patients.
Hepatitis Monthly 13(5): e7481(2013)
• Sofian M, Kalantar E, Aghakhani A, Hosseini S, Banifazl M, ….., Eslamifar A
and Ramezani A. No Correlation between Interleukin-10 Gene Promoter
Polymorphisms and Hepatitis B Virus Infection Outcome. Hepatitis Monthly
13(5): e8803 (2013)
• Ramezani A, Banifazl M, Eslamifar A , Ahmadi F, Razeghi E and Aghakhani
A. Outcome of Hemodialysis Patients with Occult Hepatitis B Virus Infection
At 4 Year Follow-up. Journal of Gastrointestinal and Liver Diseases 22(1):12-
15(2013)
• Sofian M, Sheikholeslami M, Mahdaviani F, Aghakhani A, Banifaz M,
Eslamifar A, Sarmadian H, Deiri G, Ramezani A. Low Prevalence of Brucella
agglutinins in Blood Donors in Central Province of Iran. Iranian Journal of
Microbiology 5(1):24-27(2013)
• Sofian M, Aghakhani A, FaraziA, Banifazl M, Eslamifar A, Rashidi N,
Khadem-Sadegh A and Ramezani A. Serum Profile of T helper 1 and T helper
2 Cytokines in Hepatitis C virus Infected Patients. Hepatitis Monthly
12(12):e6156 (2012)
• Sofian M, Aghakhani A, Banifazl M, Azadmanesh K, Farazi A, McFarland W,
Eslamifar A and Ramezani A. Viral hepatitis and HIV infection among
injection drug users in a central Iranian city. Journal of Addiction Medicine
6(4):292-6 (2012)
• Aghakhani A, Banifazl M, Eslamifar A, Ahmadi F and Ramezani A. Viral
Hepatitis and HIV Infection in Hemodialysis Patients. Hepatitis Monthly
12(7): 463-464(2012)
• Ramezani A, Banifazl M, Eslamifar A, Sofian M and Aghakhani A. Occult
hepatitis B infection in different high risk patients. Hepatitis Monthly 12(7):
467-468(2012)
• Aghakhani A, Banifazl M, Velayati AA, Eslamifar A and Ramezani A. Occult
Hepatitis B Virus Infection in Hemodialysis Patients: A Concept for
Consideration. Therapeutic Apheresis and Dialysis 16(4):328-33(2012)
• Ramezani A, Banifazl M, Mamishi S, Sofian M, Eslamifar A and Aghakhani
A. The Influence of Human Leukocyte Antigen and IL-10 Gene
Polymorphisms in Hepatitis B Virus Outcome. Hepatitis Monthly 12(5):320-
325(2012)
• Eslamifar A, Ramezani A, Banifazl M, Khadem-Sadegh A and Aghakhani A.
Seroprevalence of IgG Antibodies against Bordetella Pertussis in Different
Age Groups in Tehran. Iranian Journal of Pathology 7(3):171-176(2012)
• Soufian S , Aghakhani A, Mohraz M, Banifazl M, Eslamifar A, Boland-
Ghamat Z, Khadem-Sadegh A and Ramezani A. No evidence of the Th1 to
Th2 cytokine shift during the course of HIV infection. Iranian Journal of
Pathology 7(2):88-93(2012)
• Eslamifar A, Ramezani A, Banifazl M and Aghakhani A. Tetanus and
diphtheria seroprevalence in patients infected with human immunodeficiency
virus. Iranian Journal of Pathology 7(1):27-31(2012)
• Ramezani A, Banifazl M, Mohraz M, Eslamifar A, Rasoolinejad M and
Aghakhani A. Occult Hepatitis B Virus Infection: A Major Concern in HIV-
Infected Patients. Hepatitis Monthly 11(1):7-10 (2011)
• Aghakhani A, Banifazl M, Izadi N, McFarland W, Sofian M, Khadem-Sadegh
A,….Eslamifar A, Ramezani A. Persistence of antibody to hepatitis B surface
antigen among vaccinated children in a low HBV endemic area. World Journal
of Pediatrics 7(4):358-60 (2011)
• Aghakhani A, Hamkar R, Parvin M, …., Banifazl M, Eslamifar A, Izadi N,
Jam S and Ramezani A. The Role of Human Papillomavirus Infection in
Prostate Carcinoma. Scandinavian Journal of Infectious Diseases 43(1): 64-
69(2011)
• Ramezani A, Banifazl M, Eslamifar A and Aghakhani A. Association between
Human Papillomavirus Infection and Risk of Prostate Cancer (Review article).
Iranian Journal of Pathology 6 (1): 3-7(2011)
• Hamkar R, Mohraz M, Lorestani S, Aghakhani A, Truong HM, McFarland W,
Banifazl M, Eslamifar A, ……. and Ramezani A. Assessing Subtype and
Drug-Resistance Associated Mutations among Antiretroviral-Treated HIV
Infected Patients. AIDS 24 (suppl 2):S85–S91 (2010)
• Aghakhani A, Banifazl M, Kalantar E, Eslamifar A, Khadem-Sadegh A and
Ramezani A. Occult Hepatitis B Virus Infection in Hemodialysis Patients with
Isolated Hepatitis B Core Antibody: A Multicentre Study. Therapeutic
Apheresis and Dialysis 14(3):349–353 (2010)
• Ramezani A, Banifazl M, EslamifarA and Aghakhani A. Serological pattern of
anti-HBc alone infers occult hepatitis B virus infection in high-risk individuals
in Iran. Journal of Infection in Developing Countries 4(10):658-661 (2010)
• Sofian M, Aghakhani A, Farazi AA, Banifazl M, …, Eslamifar A, Khadem-
Sadegh A, Izadi N and Ramezani A. Seroepidemiology of Hepatitis A Virus in
Children of Different Age Groups in Tehran, Iran: Implications for Health
Policy. Travel Medicine and Infectious Disease 8(3): 176-179 (2010)
• Sofian M, Aghakhani A, Banifazl M, …Eslamifar A,…Ramezani A. Lack
of occult hepatitis B virus infection among blood donors with isolated anti-
HBc living in a HBV low prevalence region in Iran. International Journal
of Infectious Diseases 14(4):e308–e310 (2010)
• Hamkar R, Aghakhani A, Soufian S, Banifazl M, ….., Eslamifar A and
Ramezani A. Surface Gene Mutations of Hepatitis B Virus among High
Risk Patients with Occult HBV Infection. Diagnostic Microbiology and
Infectious Disease 66(3):285-291(2010)
• Aghakhani A, Hamkar R, Zamani N, Eslamifar A, Banifazl M,
….Ramezani A. Hepatitis B Virus Genotype in Iranian Patients with
Hepatocellular Carcinoma . International Journal of Infectious Diseas13
(6):685-89(2009).
• Ramezani A, Mohraz M, Aghakhani A, Banifazl M, Eslamifar A,
Khadem-Sadegh A, Velayati AA. Frequency of Isolated Hepatitis B Core
Antibody in HIV-HCV Coinfected Individuals. International Journal of
STD & AIDS 20(5):336-338(2009)
• Ramezani A, Aghakhani A, Kalantar E, Eslamifar A, Banifazl M and
Velayati AA. HLA-A*3303 and *3301 Predispose Patients to Persistent
Hepatitis B Infection. Journal of Gastrointestinal and Liver Diseases
18(1):117-8(2009)
• Kariminia A, sharifnia Z, Aghakhani A, Banifazl M, Eslamifar A, Hazrati
M and Ramezani A. Comparison of QuantiFERON TB-G test to TST for
detecting latent tuberculosis infection in a high-incidence area containing
BCG-vaccinated population. Journal of Evaluation in Clinical
Practice15:148–151(2009)
• Ramezani A, Eslamifar A, ……and Aghakhani A. Efficacy and Long-term
Immunogenicity of Hepatitis B Vaccine in Hemodialysis Patients.
International Journal of Clinical Practice 63(3): 394-97(2009)
• Ramezani A, Hasanjani Roshan MR, Kalantar E, Eslamifar A,….Taeb J,
Aghakhani A… Association of Human Leukocyte Antigen polymorphism
with Outcomes to Hepatitis B Virus Infection. Journal of Gastroenterology
and Hepatology 23(11):1716-1721 (2008).
• Ramezani A, Mohraz M, Vahabpour R,….Eslamifar A,….Aghakhani
A,…Hekmat S. Frequency of Hepatitis G Virus Infection among HIV
Positive Subjects with Parenteral and Sexual Exposure. Journal of
Gastrointestinal and Liver Diseases 17(3):269-72 (2008)
• Azadmanesh K, Mohraz M, Aghakhani A,……..Eslamifar A,….Ramezani
A. Occult Hepatitis B Virus Infection in HIV-Infected Patients with
Isolated Hepatitis B Core Antibody. Intervirology 51(4):270-274 (2008)
• Hekmat S, Mohraz M, Vahabpour R, Jam S, Bahramali G, Banifazl M,
Aghakhani A, Eslamifar A, Mahboudi F, Edalat R, Ramezani A.
Frequency and Genotype of GB Virus C among Iranian Patients Infected
with HIV. Journal of Medical Virology 80(11):1941-1946(2008)
• Ramezani A, Mohraz M, Banifazl M,….Eslamifar A,….and Aghakhani A.
Frequency and Associated Factors of Proteinuria in Iranian HIV-Positive
Patients. International Journal of Infectious Diseases 12(5):490-494(2008)
• Ramezani A, Eslamifar A,, ……and Aghakhani A. Persistence of Hepatitis
B Vaccine Immunity in Hemodialysis Patients .Therapeutic Apheresis and
Dialysis.12(2):143-146 (2008).
• Sofian M., Aghakhani A., Velayati A.A., Banifazl M, Eslamifar A. and
Ramezani A. Risk factors for human brucellosis in Iran: a case control
study. International Journal of Infectious Diseases 12(2):157-61(2008)
• Ramezani A. Gachkar L, Eslamifar A,….Detection of hepatitis G virus
envelope protein E2 antibody in blood donors. International Journal of
Infectious Diseases. 12(1):57-61(2008)
• Eslamifar A, Hamkar R, Ramezani A, ……and Aghakhani A. Hepatitis G
virus (HGV) Exposure in Dialysis Staff. Therapeutic Apheresis and
Dialysis. 11(5):370-374(2007)
• Norouzian D, Akbarzadeh A, …..and Eslamifar A. Stabilization of
Tyrosinase-Bovine serum albumin crystals by Glutaraldehyde. American
journal of Biochemistry and Biotechnology. 3(3):110-113(2007).
• Eslamifar Ali, Aghakhani A, Hamkar R, Ramezani A, et al..... Frequency
of Human Papillomavirus Infection in Iranian Esophageal Squamous Cell
Carcinoma patients. Scandinavian Journal of Infectious Disease .39(1):58-
62(2007)
• Eslamifar A, Hamkar R, Ramezani A, ……and Aghakhani A. Hepatitis G
Virus Exposure in Dialysis Patients. International Urology and
Nephrology .39(4): 1257-1263 (2007).
• Razzaghi-abyaneh M, Shams-Ghahfarokhi M, Eslamifar A. Inhibitory
effects of Akacid on growth and aflatoxin production by Aspergillus
parasiticus. Mycopathologia, Vol. 161: 245-249. (2006)
• Razzaghi-Abyaneh M, Shams-Ghahfarokhi M, Eslamifar A.
Ultrastructural evidences of growth inhibitory effects of a novel biocide,
Akasid. Toxicon, 48: 1075-1082. (2006)
• Sayah M, Beheshti S, Shokrgozar M.A, Eslamifar A, Deljoo Z. Anti
epileptogenic and anticonvulsant activity of interleukin 1β in amygdala-
kindled rats experimental neurology(2004)
Journal papers (Persian)
• Ramezani A, Eslamifar A, Banifazl M, Keyvani H, Razeghi E, Ahmadi F,
Amini M,Gachkar L, Bavand A, Aghakhani A. Occult HCV infection in
hemodialysis patients with elevated liver enzymes. Arak Medical
University Journal.16 (80): 34- 40 (2014)
• Eslamifar A, Aghakhani A, Mohraz M, Banifazl M, Foroughi M, Ansari F,
Bolandghamat Z, Ramezani A. Seroepidemiology of Hepatitis E Virus
Infection in HIV Infected Patients. Iranian Journal of Infectious Diseases
and Tropical Medicine 17(59):33-36(2013)
• Soufian S, Mohraz M, Aghakhani A, Banifazl M, Froughi M, Eslamifar A,
Boland-Ghamat Z, Khadem-Sadegh A and Ramezani A. TH1/TH2
Cytokine Levels in Human Immunodeficiency Virus Type 1 Infected
Patient. Iranian Journal of Infectious Diseases and Tropical Medicine
16(55):19-22(2012)
• Kalantar E, Ramezani A, Hosseini S, Aghakhani A, Zarin Far N, Banifazl
M ,………Eslamifar A and Sofian M. Interleukin-10 gene promoter
polymorphisms and hepatitis B virus infection outcome. Iranian Journal of
Infectious Diseases and Tropical Medicine 16(54):7-12(2011)
• Aghasadeghi MR, Mohraz M, Bahramali G, Aghakhani A, Banifazl
M…… Eslamifar A and Ramezani A. Frequency of hepatitis D virus
infection in HIV positive and hemodialysis patients. Iranian Journal of
Infectious Diseases and Tropical Medicine 16(54):41-46(2011)
• Ramezani A, Hamkar R, Aghakhani A, Lorestani SH, Banifazl M, Truong
HH, McFarland W, Foroughi M, Eslamifar A and Mohraz M. Subtype
Mutations and Related Drug-Resistance in Anti-Retroviral Treated HIV
Infected Patients. Iranian Journal of Infectious Diseases and Tropical
Medicine15(50):1-7(2010)
• Izadi N, Aghakhani A, Banifazl M , … Eslamifar A , .., Khadem-Sadegh A
and Ramezani A. Persistence of Anti-HBs antibody in HB Vaccinated
Children in a Low Endemic Area for HBV. Iranian Journal of Infectious
Diseases and Tropical Medicine 14(47):39-42(2010)
• Eslamifar A, Aghakhani A, Banifazl M, Gachkar L, Khadem-Sadegh A,
Ramezani A. Seroprevalence of Bordetella Pertussis Antibodies in
Different Age Groups. Iranian Journal of Infectious Diseases and Tropical
Medicine 15(49):43-47(2010)
• Hamkar R, Parvin M, Ghavami N, Ramezani A, …, Banifazl M, ….,
Eslamifar A and Aghakhani A. Involvement of Human Papillomavirus
Infection in Prostate Carcinoma. Iranian Journal of Infectious Diseases and
Tropical Medicine 15(48):13-17(2010)
• Ramezani A, Azadmanesh K, Aghakhani A, Banifazl M, …. and Sofian
M. Frequency of occult hepatitis B virus infection in injection drug users.
Iranian Journal of Infectious Diseases and Tropical Medicine 15(48):39-
42(2010)
• Ramezani A, Hamkar R, Soufian S, Banifazl M ,……, Eslamifar A and
Aghakhani A. Genetic variability of the S gene of hepatitis B virus among
High Risk Patients with Occult HBV Infection. Iranian Journal of
Infectious Diseases and Tropical Medicine 14(47):13-18(2010)
• Velayati AA, Aghakhani A,....Eslamifar A....Ramezani A. Association of
polymorphism of HLA-DRB1*13 and HLA-A*33 alleles with outcome of
hepatitis B virus infection. Iranian Journal of Infectious Diseases and
Tropical Medicine 14(46): 11-14 (2009)
• Ramezani A, Sofian M, Banifazl M, …., Eslamifar A, Gachkar L,
Khadem-Sadegh A and Aghakhani A. Seroepidemiology of Hepatitis A
Virus in Children Residing in Tehran. Iranian Journal of Infectious
Diseases and Tropical Medicine 14(46):23-26 (2009)
• Ramezani A, Banifazl M, Eslamifar A, Gachkar L, Aghakhani A.
Prevalence of hepatitis G virus in the sera of HIV infected patients with
parenteral and sexual exposure. Iranian Journal of Infectious Diseases and
Tropical Medicine 14(45):27-29(2009)
• Ramezani A, Aghakhani A,…….. Eslamifar A, Sofian M. Occult hepatitis
B virus infection among blood donors in Arak. Iranian Journal of
Infectious Diseases and Tropical Medicine 14(45):37-40(2009)
• Ramezani A, Aghakhani A, Banifazl M, Eslamifar A, Mohraz M.
Frequency of isolated anti-HBc in HIV- HCV co-infected patients. Iranian
Journal of Infectious Diseases and Tropical Medicine 14(45):17-22(2009)
• Ramezani A, Banifazl M,……Eslamifar A…..and Aghakhani A. Occult
hepatitis B virus infection in hemodialysis patients. Iranian Journal of
Infectious Diseases and Tropical Medicine14(44):27-30
• Ramezani A, Mohraz M, Banifazl M, Eslamifar A and Aghakhani A.
Significance of Hepatitis B Core Antibody as the Only Marker of Hepatitis
B Virus Infection. Iranian Journal of Pathology 4(2):80-84(2009)
• Ramezani A, Aghakhani A, Kalantar E, Banifazl M, Eslamifar A ,Velayati
AA. Association between Hepatitis B Virus Infection Outcome and HLA-
A and DRB1 Genotyping in North Part of Iran. Iranian Journal of
Pathology 4(2):71-74(2009)
• Ramezani A, Mohraz M,….,Aghakhani A, Eslamifar A…..Prevalence of
dyslipidemia and metabolic abnormalities in HIV-infected patients. Acta
Medica Iranica 47(2):83-88(2009)
• Ramezani A, ………Aghakhani A, Eslamifar A,…and Mohraz M.
Frequency of Occult Hepatitis B Virus Infection in HIV Infected Patients.
Iranian Journal of Infectious Diseases and Tropical Medicine13(43):17-
20(2009)
• Aghakhani A, Mohraz M, Banifazl M, …. Eslamifar A,…and Ramezani
A. Asymptomatic proteinuria in HIV-infected outpatients. Iranian Journal
of Infectious Diseases and Tropical Medicine 13(42):9-13(2008)
• Ramezani A, Eslamifar A,…… Aghakhani A ,…. High Blood Mercury
Levels in Iranian Infants: cause for concern. Iranian Journal of Pathology
3(4):186-190 (2008)
• Zahmatkesh M, Khadkhodaie M, …..Eslamifar A, Taeb J,…Proteinuria is
reduced by inhibition of inducible nitric oxide synthase in rat renal
ischemia/perfusion injury. Urmia Medical Journal.19(2):34-41(2008)
• Eslamifar A, Razzaghi-Abyaneh M,…… Ramezani A, Deljoodokht Z and
Aghakhani A. Frequency and Identification of Fungal Strains in Chronic
Rhinosinusitis Patients. Iranian Journal of Pathology 3(3):135-139(2008)
• Ramezani A, Aghakhani A ,… Eslamifar A,….Anemia prevalence and
related factors in a cohort of HIV- infected patients .Iranian Journal of
Pathology 3(3):125-128(2008)
• Hamkar R, Zamani N, Ramezani A, Eslamifar A, ......and Aghakhani A.
Identification of Hepatitis B Virus Genotype in Iranian Hepatocellular
Carcinoma Patients. Iranian Journal of Infectious Diseases and Tropical
Medicine13(41):23-29(2008)
• Ramezani A,…… Aghakhani A, Eslamifar A,….. Prevalence and
Genotype of Hepatitis G virus infection in HIV Positive Patients. Iranian
Journal of Infectious Diseases and Tropical Medicine13(41):7-13(2008)
• Ramezani A, Aghakhani A, Eslamifar A….Taeb J,….. Long-Term
Immunity of Hepatitis B Vaccine in Patients Undergoing Hemodialysis.
Iranian Journal of Infectious Diseases and Tropical Medicine.13(40):21-
24(2008)
• Kariminia A, sharifnia Z, Aghakhani A, .. Eslamifar A,… and Ramezani
A. Evaluation of the blood gamma interferon assay for detection of latent
Tuberculosis infection: potential to replace the Mantoux skin test. Iranian
Journal of Infectious Diseases and Tropical Medicine13 (40):1-4(2008).
• Eslamifar A, Ramezani A, Razzaghi Abyaneh M, Fallahian V,
Mashayekhi P, Hazrati M, Askari T, Fayaz A and Aghakhani A. Animal
Bites in Tehran, Iran. Archives of Iranian Medicine 11(2):200-202(2008)
• Ramezani A, Mohraz M, Banifazl M,….Eslamifar A,….and Aghakhani A.
Metabolic abnormalities in HIV-positive patients receiving highly active
antiretroviral therapy. Iranian Journal of Pathology2 (4):154-58 (2007).
• Jam S, Sabzevari D, Aghakhani A, Eslamifar A, Banifazl M and Ramezani
A. Antimicrobial susceptibility pattern of clinical isolates of Pseudomonas
aeruginosa in a pediatric hospital. Iranian Journal of Pathology 2(4):144-
48(2007)
• Soofian M,…. Eslamifar A, Aghakhani A, Ramezani A. Eosinophilic
gastroenteritis: A case report. Iranian Journal of Infectious Disease and
Tropical Medicine .12(38):63-6(2007).
• Ramezani A, Eslamifar A, Aghakhani A,…..Blood mercury levels in
infants receiving vaccines containing Thimerosal. Iranian Journal of
Infectious Disease and Tropical Medicine. 12(38):17-20(2007).
• Eslamifar A, Tirgari F, Hamkar R, Ramezani A …… Deljoodokht Z and
Aghakhani A. Role of the Human Papillomavirus infection in Esophageal
Squamous Cell Carcinoma. Iranian Journal of Pathology. 2(1):11-
16(2007).
• Naraghi M, Amidi Y, Eslamifar A. Demonstration of microbial biofilm in
Ethmoidal sinus of refractory chronic rhinosinusitis patients by SEM. The
Iranian journal of Otorhinolaryngology 18(46):181-4(2007).
• Ramezani A, Gachkar L, Eslamifar A…Prevalence of Hepatitis G virus
exposure in blood donors. Infectious diseases and tropical medicine
journal. 37(12).( 2007).
• Mahmoodi SMM, Hamkar R, …Eslamifar A…Determination of Human
Papillomavirus genotypes in cervical cancer speciemens in Yazd province.
Infectious diseases and tropical medicine journal. 37(12)( 2007).
• Ramezani A, Aghakhani A……Eslamifar A…. Natural YMDD mutants in
chronic B hepatitis. Iranian Journal of Infectious Diseases and Tropical
Medicine. 12(37): 1-6(2007).
• Eslamifar Ali, Aghakhani A, Hamkar R, Ramezani A,..... Frequency of
Human Papillomavirus Infection in Iranian Esophageal Squamous Cell
Carcinoma patients. Scandinavian Journal of Infectious Disease .39(1):58-
62(2007).
• Eslamifar A., Aghakhani A. Ramezani A.,... Detection of Hepatitis G
Virus Envelope Protein E2 Antibody in Dialysis Staff .Iranian Journal of
Infectious Diseases and Tropical Medicine. 11(35): 73-79 (2007).
• Eslamifar A., Aghakhani A. , Hamkar R., Ramezani A., Tirgari F., Frootan
H., Mirmomen Sh., Gheini MH. , Deljoodookht Z., Taeb J. Detection of
High Risk Human Papillomaviruses in Esophageal Squamous Cell
Carcinoma by PCR and DNA Sequencing. Iranian Journal of Infectious
Disease and Tropical Medicine. 11(33): 1-5(2006).
• Shahabi P, Mirnajafi J, Eslamifar A, Deljoo Z. Influence of electrical
destruction of Amygdal on convulsion due to..... Physiology and
Pharmacology Journal, Vol. 9, No. 2. (2005)
• Ramezani A, Mohraz M, Feizabadi M, Asgharzadeh A, Parastan R,
Eslamifar A, Aliahmadi A, Velayati A.A Molecular epidemiology of
clinical strains of enteococci Faecium in Tehran hospitals. Infectious
Diseases and Tropical Medicine Journal, Vol. 10, No. 31. .(2005)
• Ramezani A, Eslamifar A, Hazrati M. Study vaccine includes thiomersal
and relations with neurodevelopment disorders in neonates and embryonic
periods. Iranian Journal of Infectious Disease and Tropical Medicine, Vol.
9, No. 26. (2004)
• Ramezani A, Eslamifar A, Eslami N, Nazgooie F. Epidemiology of animal
rabies in Tehran province. Iranian Journal of Infectious Disease and
Tropical Medicine, Vol. 9, No. 25. (2004)
• Ramezani A, Eslamifar A, Nazgooie F, Falahian L, Hazrati M, Naseri
M.R. (2004) Study Epidemiology of animal bites in persons referred to
Institute Pasteur of Iran (Tehran province). Iranian Journal of Infectious
Disease and Tropical Medicine. Vol. 9, No. 27.( 2003)
• Ramezani A, Mohraz M, Asadi S, Nazgooie F, Eslamifar A. Survey
situation of nosocomial infection due to enterococci in Tehran hospitals.
Infectious Diseases and Tropical Medicine Journal, Vol. 7, No. 19. (2002)
Books:
• New edition of "Guide to antimicrobial therapy and vaccination" .Chief
Editor: Iranian Society for Infectious Diseases and Tropical Medicine
publication (2013)
• New edition of "Guide to antimicrobial therapy and vaccination". Pousheh
Publication, Tehran, Iran (2012)
• New edition of "Guide to antimicrobial therapy" .Chief Editor: Iranian
society for infectious diseases and tropical medicine publication
( 2005,2006,2007,2008,2009,2010)
• Application of Nanotechnology in medicine, Sharh Publication, Tehran
(2005).
• Health for Everybody. ISBN: 964-5888-81-6. Ahrar Publication in Tabriz
(2005)